The authors reply

Affiliations

¹ Department of Pharmacy and Therapeutic, University of Pittsburgh Medical Center, Pittsburgh, PA.
² Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.

Comment

Ryan M Rivosecchi et al. Crit Care Med. 2021.

. 2021 Oct 1;49(10):e1059-e1060.

doi: 10.1097/CCM.0000000000005236.

¹ Department of Pharmacy and Therapeutic, University of Pittsburgh Medical Center, Pittsburgh, PA.
² Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.

No abstract available

Conflict of interest statement

Dr. Sanchez has disclosed that he does not have any potential conflicts of interest.

Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
Rivosecchi RM, Arakelians AR, Ryan J, Murray H, Ramanan R, Gomez H, Phillips D, Sciortino C, Arlia P, Freeman D, Sappington PL, Sanchez PG. Rivosecchi RM, et al. Crit Care Med. 2021 Jul 1;49(7):1129-1136. doi: 10.1097/CCM.0000000000004944. Crit Care Med. 2021. PMID: 33711003
Bivalirudin Superior to Heparin for Extracorporeal Membrane Oxygenation: Not So Fast.
Mazzeffi MA, Plazak M, Dalton H. Mazzeffi MA, et al. Crit Care Med. 2021 Oct 1;49(10):e1057-e1058. doi: 10.1097/CCM.0000000000005103. Crit Care Med. 2021. PMID: 34529629 No abstract available.

1. Mazzeffi MA, Plazak M, Dalton H: Bivalirudin Superior to Heparin for Extracorporeal Membrane Oxygenation: Not So Fast. Crit Care Med. 2021; 49:e1057–e1058
1. Rivosecchi RM, Arakelians AR, Ryan J, et al.: Comparison of anticoagulation strategies in patients requiring venovenous extracorporeal membrane oxygenation: Heparin versus bivalirudin. Crit Care Med. 2021; 49:1129–1136
1. Hawley S, Ali MS, Berencsi K, et al.: Sample size and power considerations for ordinary least squares interrupted time series analysis: A simulation study. Clin Epidemiol. 2019; 11:197–205
1. Vera-Aguilera J, Yousef H, Beltran-Melgarejo D, et al.: Clinical scenarios for discordant anti-Xa. Adv Hematol. 2016; 2016:4054806